75 related articles for article (PubMed ID: 22434366)
1. (-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption.
Lee SH; Kim BJ; Choi HJ; Cho SW; Shin CS; Park SY; Lee YS; Lee SY; Kim HH; Kim GS; Koh JM
Calcif Tissue Int; 2012 May; 90(5):404-10. PubMed ID: 22434366
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate improves bone microarchitecture in ovariectomized rats.
Chen CH; Kang L; Lin RW; Fu YC; Lin YS; Chang JK; Chen HT; Chen CH; Lin SY; Wang GJ; Ho ML
Menopause; 2013 Jun; 20(6):687-94. PubMed ID: 23511703
[TBL] [Abstract][Full Text] [Related]
3. Hispidulin exerts anti-osteoporotic activity in ovariectomized mice via activating AMPK signaling pathway.
Zhou R; Wang Z; Ma C
Cell Biochem Biophys; 2014 Jun; 69(2):311-7. PubMed ID: 24338527
[TBL] [Abstract][Full Text] [Related]
4. Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice.
Xiang A; Kanematsu M; Kumar S; Yamashita D; Kaise T; Kikkawa H; Asano S; Kinoshita M
Bone; 2007 May; 40(5):1231-7. PubMed ID: 17347064
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency.
Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G
J Bone Miner Res; 2000 Aug; 15(8):1510-6. PubMed ID: 10934649
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
7. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats.
Nian H; Qin LP; Chen WS; Zhang QY; Zheng HC; Wang Y
Acta Pharmacol Sin; 2006 Jun; 27(6):728-34. PubMed ID: 16723092
[TBL] [Abstract][Full Text] [Related]
9. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
Cui L; Wu T; Liu YY; Deng YF; Ai CM; Chen HQ
Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
[TBL] [Abstract][Full Text] [Related]
11. Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice.
Hankenson KD; James IE; Apone S; Stroup GB; Blake SM; Liang X; Lark MW; Bornstein P
Matrix Biol; 2005 Aug; 24(5):362-70. PubMed ID: 15979292
[TBL] [Abstract][Full Text] [Related]
12. Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice.
Kim D; Cho SW; Her SJ; Yang JY; Kim SW; Kim SY; Shin CS
Stem Cells; 2006 Jul; 24(7):1798-805. PubMed ID: 16556708
[TBL] [Abstract][Full Text] [Related]
13. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
14. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
Kodama I; Niida S; Sanada M; Yoshiko Y; Tsuda M; Maeda N; Ohama K
J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389
[TBL] [Abstract][Full Text] [Related]
16. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model.
He YX; Zhang G; Pan XH; Liu Z; Zheng LZ; Chan CW; Lee KM; Cao YP; Li G; Wei L; Hung LK; Leung KS; Qin L
Bone; 2011 Jun; 48(6):1388-400. PubMed ID: 21421090
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
[TBL] [Abstract][Full Text] [Related]
18. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
Yun JH; Pang EK; Kim CS; Yoo YJ; Cho KS; Chai JK; Kim CK; Choi SH
J Periodontal Res; 2004 Oct; 39(5):300-7. PubMed ID: 15324350
[TBL] [Abstract][Full Text] [Related]
20. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
Murase T; Misawa K; Haramizu S; Hase T
Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
